| Trial ID: | L2342 |
| Source ID: | NCT00889226
|
| Associated Drug: |
Pitavastatin
|
| Title: |
Efficacy and Safety Study of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With Hypercholesterolemia
|
| Acronym: |
ESPRIT
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00889226/results
|
| Conditions: |
Hypercholesterolemia With Type2DM
|
| Interventions: |
DRUG: Pitavastatin|DRUG: Atorvastatin
|
| Outcome Measures: |
Primary: Proportion of Patients Achieving LDL- C<100mg/dL, compare the proportion of patients achieving LDL- C\<100mg/dL, After 16wk drug administration | Secondary: The Change of LDL-C, The change of LDL-C between at 16-week and baseline, After 16wk drug administration
|
| Sponsor/Collaborators: |
Sponsor: JW Pharmaceutical
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
161
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-04
|
| Completion Date: |
2010-01
|
| Results First Posted: |
2019-09-17
|
| Last Update Posted: |
2019-09-17
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00889226
|
